Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype

Similar Items

• The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
  od: Ragnum, H B, i dr.
  Izdano: (2015)
• Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype
  od: Barathova, M, i dr.
  Izdano: (2008)
• Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
  od: Couvelard, A, i dr.
  Izdano: (2005)
• PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
  od: Molleví, D G, i dr.
  Izdano: (2008)
• Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours
  od: Childs, Alexa, i dr.
  Izdano: (2016)